Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-223 [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating AD-223 for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AD-223

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypertension,Essential | Phase 3 | Status: COMPLETED